Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.34 -0.01 (-0.43%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kiora Pharmaceuticals (KPRX) Non Operating Income (2014 - 2026)

Updated

Kiora Pharmaceuticals (KPRX) reported Non Operating Income of $134,761 for Q2 2026, up 2.3% from $131,680 a year earlier and up 46.1% from the prior quarter.

Analysis

Kiora Pharmaceuticals (KPRX) Non Operating Income (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kiora Pharmaceuticals' Non Operating Income came in at $548,682, down 44.4% year-over-year; for FY2025, it came in at $713,770, down 37.9% from FY2024.

  • Non Operating Income has a five-year compound annual growth rate of 106.2% (FY2020 to FY2025).
  • By year, Non Operating Income came in at $1.15 million in FY2024 (+603.8%), $163,319 in FY2023, -$1.39 million in FY2022 and $272,480 in FY2021.
  • Five-year quarterly Non Operating Income spans a low of -$1.42 million in Q3 2022 and a high of $406,185 in Q4 2024.
  • Year over year, Non Operating Income gained in three of the last seven quarters, with an average decline of 22.5%.
  • The high point for year-over-year Non Operating Income in five years was Q1 2023 (growth of 987.0%); the low point was Q2 2022 (a decline of 99.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $92,212 (Q1 2026), $143,595 (Q4 2025) and $178,114 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 387.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Kiora Pharmaceuticals 14.34 Mn -52.98 Mn - 134,761.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 134,761.00
Mar 31, 2026 92,212.00
Dec 31, 2025 143,595.00
Sep 30, 2025 178,114.00
Jun 30, 2025 131,680.00
Mar 31, 2025 260,380.00
Dec 31, 2024 406,185.00
Sep 30, 2024 188,911.00
Jun 30, 2024 323,241.00
Mar 31, 2024 231,113.00
Dec 31, 2023 -59,638.00
Sep 30, 2023 155,627.00
Jun 30, 2023 19,199.00
Mar 31, 2023 48,131.00
Dec 31, 2022 23,542.00
Sep 30, 2022 -1.42 Mn
Jun 30, 2022 1,237.00
Mar 31, 2022 4,428.00
Dec 31, 2021 -3,832.00
Sep 30, 2021 259.00
API Access

Kiora Pharmaceuticals Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=KPRX&period=max&api_key=YOUR_API_KEY